
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Preclinical Pharmacology |
Institute for Prevention of Cardiovascular Diseases, Ludwig Maximilians University, Munich, 80336 Germany [T. W., N. G., A. S., W. E., C. W., J. N.]; Division of Pathology II, University Hospital, Linköping SE-581 85, Sweden [A. T., U. T. B., J. N.]; Department of Medicine and Cell Biology, Vanderbilt University, Nashville, Tennessee 37235 [M. L., R. J. C.]; Institute of Molecular Genetics, Czech Academy of Sciences, Prague, 14220 Czech Republic [L. A., V. K.]; Institute of Molecular Animal Breeding, Ludwig Maximilians University, Munich, 81377 Germany [H. L.]; Department of Pharmaceutical Sciences, Washington State University, Pullman, Washington 99164 [M. W. F.]; Institute of Medical Biochemistry, University of Graz, 8010 Graz, Austria [W. S.]; Department of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, Illinois 60612 [D. S. U.]; and Department of Cardiovascular Molecular Biology, University Hospital, Aachen, 52057 Germany [C. W.]
-Tocopheryl succinate (
-TOS), a redox-inactive analogue of vitamin E, is a strong inducer of apoptosis, whereas
-tocopherol (
-TOH) lacks apoptogenic activity (J. Neuzil et al., FASEB J., 15: 403415, 2001). Here we investigated the possible antineoplastic activities of
-TOH and
-TOS and further explored the potential of
-TOS as an antitumor agent. Using nude mice with colon cancer xenografts, we found that
-TOH exerted modest antitumor activity and acted by inhibiting tumor cell proliferation. In contrast,
-TOS showed a more profound antitumor effect, at both the level of inhibition of proliferation and induction of tumor cell apoptosis.
-TOS was nontoxic to normal cells and tissues, triggered apoptosis in p53-/- and p21Waf1/Cip1(-/-) cancer cells, and exerted a cooperative proapoptotic activity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) due to differences in proapoptotic signaling. Finally,
-TOS cooperated with tumor necrosis factor-related apoptosis-inducing ligand in suppression of tumor growth in vivo. Vitamin E succinate is thus a potent and highly specific anticancer agent and/or adjuvant of considerable therapeutic potential.
This article has been cited by other articles:
![]() |
X. Gu, X. Song, Y. Dong, H. Cai, E. Walters, R. Zhang, X. Pang, T. Xie, Y. Guo, R. Sridhar, et al. Vitamin E Succinate Induces Ceramide-Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma In vitro and In vivo Clin. Cancer Res., March 15, 2008; 14(6): 1840 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-F. Dong, E. Swettenham, J. Eliasson, X.-F. Wang, M. Gold, Y. Medunic, M. Stantic, P. Low, L. Prochazka, P. K. Witting, et al. Vitamin E Analogues Inhibit Angiogenesis by Selective Induction of Apoptosis in Proliferating Endothelial Cells: The Role of Oxidative Stress Cancer Res., December 15, 2007; 67(24): 11906 - 11913. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Neuzil, M. Tomasetti, Y. Zhao, L.-F. Dong, M. Birringer, X.-F. Wang, P. Low, K. Wu, B. A. Salvatore, and S. J. Ralph Vitamin E Analogs, a Novel Group of "Mitocans," as Anticancer Agents: The Importance of Being Redox-Silent Mol. Pharmacol., May 1, 2007; 71(5): 1185 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-F. Wang, M. Birringer, L.-F. Dong, P. Veprek, P. Low, E. Swettenham, M. Stantic, L.-H. Yuan, R. Zobalova, K. Wu, et al. A Peptide Conjugate of Vitamin E Succinate Targets Breast Cancer Cells with High ErbB2 Expression Cancer Res., April 1, 2007; 67(7): 3337 - 3344. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Shiau, J.-W. Huang, D.-S. Wang, J.-R. Weng, C.-C. Yang, C.-H. Lin, C. Li, and C.-S. Chen {alpha}-Tocopheryl Succinate Induces Apoptosis in Prostate Cancer Cells in Part through Inhibition of Bcl-xL/Bcl-2 Function J. Biol. Chem., April 28, 2006; 281(17): 11819 - 11825. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Donapaty, S. Louis, E. Horvath, J. Kun, S. M. Sebti, and M. P. Malafa RRR-{alpha}-Tocopherol succinate down-regulates oncogenic Ras signaling. Mol. Cancer Ther., February 1, 2006; 5(2): 309 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stapelberg, N. Gellert, E. Swettenham, M. Tomasetti, P. K. Witting, A. Procopio, and J. Neuzil {alpha}-Tocopheryl Succinate Inhibits Malignant Mesothelioma by Disrupting the Fibroblast Growth Factor Autocrine Loop: MECHANISM AND THE ROLE OF OXIDATIVE STRESS J. Biol. Chem., July 8, 2005; 280(27): 25369 - 25376. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zu, L. Hawthorn, and C. Ip Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by {alpha}-tocopheryl succinate in human prostate cancer cells Mol. Cancer Ther., January 1, 2005; 4(1): 43 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Lawson, K. Anderson, M. Simmons-Menchaca, J. Atkinson, L. Sun, B. G. Sanders, and K. Kline Comparison of Vitamin E Derivatives {alpha}-TEA and VES in Reduction of Mouse Mammary Tumor Burden and Metastasis Experimental Biology and Medicine, October 1, 2004; 229(9): 954 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Anderson, M. Simmons-Menchaca, K. A. Lawson, J. Atkinson, B. G. Sanders, and K. Kline Differential Response of Human Ovarian Cancer Cells to Induction of Apoptosis by Vitamin E Succinate and Vitamin E Analogue, {alpha}-TEA Cancer Res., June 15, 2004; 64(12): 4263 - 4269. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zu and C. Ip Synergy between Selenium and Vitamin E in Apoptosis Induction Is Associated with Activation of Distinctive Initiator Caspases in Human Prostate Cancer Cells Cancer Res., October 15, 2003; 63(20): 6988 - 6995. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yu, B. G. Sanders, and K. Kline RRR-{alpha}-Tocopheryl Succinate-induced Apoptosis of Human Breast Cancer Cells Involves Bax Translocation to Mitochondria Cancer Res., May 15, 2003; 63(10): 2483 - 2491. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Prasad, B. Kumar, X.-D. Yan, A. J. Hanson, and W. C. Cole {alpha}-Tocopheryl Succinate, the Most Effective Form of Vitamin E for Adjuvant Cancer Treatment: A Review J. Am. Coll. Nutr., April 1, 2003; 22(2): 108 - 117. [Abstract] [Full Text] |
||||
![]() |
R. Brigelius-Flohe, F. J Kelly, J. T Salonen, J. Neuzil, J.-M. Zingg, and A. Azzi The European perspective on vitamin E: current knowledge and future research Am. J. Clinical Nutrition, October 1, 2002; 76(4): 703 - 716. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |